Possibia

2077543

Last Update Posted: 2020-03-25

Recruiting status is unknown

All Genders

accepted

18 Years-80 Years

150 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma

The purpose of the study is to determine the clinical safety and operability of the innovative tissue imprint device ProTool.

Current limitations in the management of high grade brain tumors partly reside in the lack of access to pathological tissue.

Conventional biopsy devices can cause severe side effects, thus limiting the amount of tissue that can be collected for molecular characterization. The Brain-Tissue-Imprint Devices evaluated in this trial offers a unique opportunity to perform multiple non-lesion sampling in both tumor tissue and peritumoral areas. The approach relies on the use of tailored silicon chips integrated in surgical devices enabling tissue sampling through a brief "silicon to tissue contact", thus limiting potential side effects, and opening a way to extensive molecular investigation of brain tumors and their microenvironment.

Eligibility

Relevant conditions:

Glioma : Oligodendroglioma or Astrocytoma

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Data sourced from ClinicalTrials.gov